Use of Anti-IL-20 antibody for treating rheumatoid arthrits and osteoporosis

Ming-Shi Chang

Use of Anti-IL-20 antibody for treating rheumatoid arthrits and osteoporosis

Ming-Shi Chang (Inventor)

Department of Biochemistry and Molecular Biology

Research output: Patent

Abstract

Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.

Original language	English
Patent number	8206712
Publication status	Published - 2011 Jan 6

Cite this

@misc{adecc98f23914aec95ac273f62324d2c,

title = "Use of Anti-IL-20 antibody for treating rheumatoid arthrits and osteoporosis",

abstract = "Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.",

author = "Ming-Shi Chang",

year = "2011",

month = jan,

day = "6",

language = "English",

type = "Patent",

note = "8206712",

}

TY - PAT

T1 - Use of Anti-IL-20 antibody for treating rheumatoid arthrits and osteoporosis

AU - Chang, Ming-Shi

PY - 2011/1/6

Y1 - 2011/1/6

N2 - Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.

AB - Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.

M3 - Patent

M1 - 8206712

ER -

Use of Anti-IL-20 antibody for treating rheumatoid arthrits and osteoporosis

Abstract

Fingerprint

Cite this